Clinical Trials Logo

Cocaine-Related Disorders clinical trials

View clinical trials related to Cocaine-Related Disorders.

Filter by:

NCT ID: NCT03242928 Not yet recruiting - Clinical trials for Cocaine-related Disorder

Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)

Start date: November 30, 2017
Phase: Phase 2
Study type: Interventional

This will assess whether AFQ056 can have a beneficial effect by reducing cocaine use in Cocaine Use Disorder (CUD) patients as assessed by Timeline Follow-Back cocaine self-report.

NCT ID: NCT03238859 Recruiting - Alcohol Dependence Clinical Trials

10 Days of Theta Burst Stimulation as a Tool to Treat Cocaine Dependence

Start date: August 1, 2016
Phase: Phase 2
Study type: Interventional

The goal of this double-blind sham controlled study is to evaluate the effeicacy of continuous theta burst stimulation to the frontal pole as a tool to decrease drug cue reactivity and improve treatment outcomes in treatment-engaged cocaine and alcohol users. All participants will be randomized to receive 10 days of real or sham rTMS to the frontal pole. Brain imaging data and behavioral assessments will be collected at 4 time points - before TMS, after 10 days of TMS, 1 month follow up and 2 month follow up.

NCT ID: NCT03143543 Recruiting - Clinical trials for Opioid-Related Disorders

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder

Start date: July 2015
Phase: Phase 1
Study type: Interventional

The purpose of Project 2 is to execute phase I functional magnetic resonance imaging (fMRI) studies to assess the effects of lorcaserin on brain target engagement (measured by fMRI brain activation and neural connectivity) in cocaine use disorder (CocUD) subjects and/or opioid use disorder.

NCT ID: NCT03090269 Not yet recruiting - Clinical trials for Substance-Related Disorders

Methylphenidate for Cocaine Dependence

ANRS STIMAGO
Start date: December 31, 2017
Phase: Phase 2
Study type: Interventional

This phase II pilot study aims at evaluating the benefits and the risks of methylphenidate (Concerta®) for the treatment of cocaine/crack dependence in terms of cocaine/crack use reduction and adverse events.

NCT ID: NCT03025321 Not yet recruiting - Cocaine Addiction Clinical Trials

Effects of Repetitive tDCS on Relapse in Cocaine Addiction: EMA Study

Start date: January 2017
Phase: N/A
Study type: Interventional

Repetitive bilateral (left cathodal/ right anodal) transcranial Direct Current Stimulation (tDCS) over the dorsolateral prefrontal cortex (DLPFC) seems to reduce craving and relapse risk. However, little is known about the relapse rates in cocaine addiction after tDCS, despite the need for new treatment interventions to reduce the high relapse rates in cocaine addiction. The investigators aim to explore the effects of repetitive tDCS in a larger sample (N=80) of cocaine addicted patients on number of relapse days after three months. In addition, the underlying working mechanism will be explored (e.g. cognitive control functioning). Ecological momentary assessment (EMA) will be used to measure relapse, craving and mood since retrospective self-reports seem to be less reliable in this respect.

NCT ID: NCT03018236 Recruiting - Cocaine Addiction Clinical Trials

Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.

Start date: January 2017
Phase: Phase 4
Study type: Interventional

This study evaluates the use of N-acetylcysteine in the treatment of alcohol and cocaine use disorders. Alcohol users will be split in two groups, one will receive the active N-acetylcysteine and the other placebo. The same division will occur with cocaine users. The effects of N-acetylcysteine in adherence, abstinence, psychiatric symptoms and stress biomarkers will be evaluated.

NCT ID: NCT03007394 Recruiting - Clinical trials for Cocaine-Related Disorders

Lorcaserin in the Treatment of Cocaine Use Disorder

Start date: June 19, 2017
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

NCT ID: NCT02994875 Recruiting - Cocaine Dependence Clinical Trials

Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence

Start date: May 2016
Phase: Phase 0
Study type: Interventional

The objective of this research is to identify the functional neural mechanisms (as assessed using fMRI) of short-term N-acetylcysteine (NAC) administration among methadone-maintained individuals with cocaine dependence.

NCT ID: NCT02986438 Recruiting - Clinical trials for Cocaine-Related Disorders

Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity.

TMS_COC_CONN
Start date: May 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the short and long term clinical and cognitive effects of repetitive Transcranial Magnetic Stimulation (rTMS) at 5 Hz and/or 10 Hz frequencies on the left dorsolateral prefrontal cortex in cocaine dependent patients and to examine possible changes in brain structure and functional connectivity associated with this intervention.

NCT ID: NCT02939352 Completed - Alcoholism Clinical Trials

The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues

addictionTBS
Start date: September 2014
Phase: Phase 1
Study type: Interventional

High relapse rates among substance dependent individuals are likely due to a combination of factors that involve limbic circuits in the brain involved in craving, including vulnerability to salient cues. Emerging data suggests that non-invasive, targeted brain stimulation may be able to modulate activity in these circuits and decrease craving. The primary goal of this pilot study is to determine the extent to which a single session of continuous theta burst stimulation (TBS) to the medial prefrontal cortex can attenuate limbic circuitry involved in craving among cocaine users and alcohol users. This will be tested through a double-blind,sham-controlled brain stimulation and brain imaging study in a cohort of polysubstance abusers and alcohol users.